HiberCell

Biotech

hibercell.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
40
10 granted · 30 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2382MediWound Ltd.—$31M
2383SALIX PHARMACEUTICALS LTD—$750M
2384Stemsynergy Therapeutic——
2385HiberCell——
2386RaeSedo, LLC——
2387Rakuten Medical, Inc.—$887M
2388Avalo Therapeutics—$182M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 10 granted of 40

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.